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Bovine gammaherpesvirus 4 (BoHV-4) is a herpesvirus widespread in cattle populations, 
and with no clear disease association. Its genome contains a long unique coding region 
(LUR) flanked by polyrepetitive DNA and 79 open reading frames (ORFs), with unique 17 
ORFs, named Bo1 to Bo17. In 2009, a BoHV-4 strain was isolated (FMV09-1180503: 
BoHV-4-FMV) from cattle with respiratory disease from Quebec, Canada, and its LUR 
was sequenced. Despite the overall high similarity, BoHV-4-FMV had the most divergent 
LUR sequence compared to the two known BoHV-4 reference strain genomes; most 
of the divergences were in the Bo genes and in the repeat regions. Our phylogenetic 
analysis based on DNA polymerase and thymidine kinase genes revealed that virus 
isolate was BoHV-4 gammaherpesvirus and clustered it together with European BoHV-4 
strains. Because BoHV-4-FMV was isolated from animals presenting respiratory signs, 
we have updated the BoHV-4 Canadian cattle seroprevalence data and tried to find 
out whether there is a link between clinical manifestation and BoHV-4 seropositivity. An 
indirect immunofluorescence assay (IFA) was performed with nearly 200 randomized 
sera of dairy cattle from two Canadian provinces, Quebec (n = 100) and Ontario (n = 91). 
An additional set of sera obtained from Quebec, from the healthy (n = 48) cows or from 
the animals experiencing respiratory or reproductive problems (n = 75), was also ana-
lyzed by IFA. BoHV-4 seroprevalence in Canadian dairy cattle was 7.9% (Quebec: 6% 
and Ontario: 9.9%). Among animals from the Quebec-based farms, diseased animals 
showed higher BoHV-4 seropositivity than healthy animals (P < 0.05), with a significant 
2.494 odds ratio of being seropositive in sick compared to healthy animals. Although 
there is no established direct link between BoHV-4 and specific diseases, these sero-
prevalence data suggest the possible involvement of BoHV-4 in dairy cattle diseases.
Keywords: bovine gammaherpesvirus 4, long unique coding region, phylogenetic analysis, seroprevalence, cattle 
infectious diseases
2Gagnon et al. BoHV-4: Involvement in Cattle Diseases
Frontiers in Veterinary Science | www.frontiersin.org June 2017 | Volume 4 | Article 92
inTrODUcTiOn
Bovine gammaherpesvirus 4 (BoHV-4) is a widespread cattle 
virus with no clear association with disease. It has been isolated 
from animals with a variety of clinical manifestations, yet it also 
produces a lifelong and asymptomatic infection in the majority 
of affected animals (1, 2). BoHV-4 has been described mainly as a 
secondary pathogen implicated in reproductive disorders of cattle 
(3, 4). However, recently a potential pathogenic role of BoHV-4 
in the development of the bovine dermatitis, pyrexia, and hemor-
rhagic syndrome was suggested (5). It belongs to the Herpesviridae 
family, Gammaherpesvirinae subfamily, and Rhadinovirus genus 
(6). This virus shares molecular similarity with human gam-
maherpesviruses Epstein–Barr virus and Herpesvirus saimiri  
(1, 7). However, BoHV-4 presents distinct antigenic and genomic 
characteristics compared to bovine alphaherpesvirus 1, 2, and 5 
(BoHV-1, BoHV-2, and BoHV-5, respectively), which are placed 
within the Alphaherpesvirinae subfamily (4, 6, 8).
Unlike most other gammaherpesviruses, BoHV-4 is able to 
easily replicate in a variety of cell lines in vitro and in a broad 
range of host species in vivo (7, 9). The natural host of the virus is 
primarily cattle, but several ruminant and non-ruminant species 
are susceptible to BoHV-4 infection (10, 11). Wild African buf-
faloes (Syncerus caffer) can be considered as a reservoir species, 
in which the virus is highly prevalent (11, 12). This virus was first 
isolated in Europe from cattle with respiratory diseases (13) and 
later in the United States (14). Since then, more than 40 BoHV-4 
strains have been isolated worldwide (11). These genomic and 
antigenic related strains can be classified into three groups based 
on genomic analysis: Movar 33/63-like viruses, mostly isolated 
from Europe; DN599-like viruses, mostly isolated from North 
America; and African buffalo strains (1, 11–15).
The BoHV-4 genome is a double-stranded DNA of 144 ± 6 kb, 
composed of a long unique coding region (LUR) containing at 
least 79 open reading frames, flanked at both ends by multiple 
copies of tandem repeats, called polyrepetitive DNA (1, 7, 16). 
The entire genome of two BoHV-4 strains, one from the United 
States (strain 66-p-347) (7) and the other from Belgium (strain 
V.test) (17), have been sequenced so far. Although BoHV-4 
genome organization features, which are potentially important 
for viral replication, have already been identified (17), the func-
tion of some of the genes remains unknown.
The pathogenic role of BoHV-4 is still not clear, since it was 
isolated from a wide variety of clinical cases as well as from 
apparently healthy animals (1, 9, 13). BoHV-4 has been found 
in cattle affected by respiratory disorders (13), metritis, endo-
metritis, and pelvic inflammatory disease (4, 18–20), orchitis, 
vulvovaginitis, and abortion (3, 21, 22), neurological disorders 
(23), diarrhea and skin lesions (1, 24), and rare bovine derma-
titis, pyrexia, and hemorrhagic syndrome (5). The viral DNA 
was also detected in semen (25), in aborted fetuses (26), and 
milk, and considered as a potential cause of mastitis (27–29). 
Additionally, the potential of BoHV-4 transmission via embryo 
transfer was recently reported (30). However, several clinical 
trials of controlled infection failed to reproduce disease, and 
no correlation was found between the presence of histological 
lesions and BoHV-4 infection (1, 4, 9).
As for other herpesviruses, BoHV-4 is able to establish 
latent infection (31). Although the presence of BoHV-4 has 
been demon strated in many tissues, one site of persistence in 
both natural and experimental hosts is the cells of the mac-
rophage/monocyte lineage (31, 32). Other potential sites of 
viral persistency are the trigeminal ganglia (TG), because it was 
shown that BoHV-4 DNA was present in the TG of naturally 
infected cattle, similar to the BoHV-2, which usually establish 
latency in neuronal tissues (33). Virus reactivation is possible 
following dexamethasone treatment and stress factors and, 
frequently, virus reactivation occurs in the absence of clinical 
disease (32). Thus, the latent character of BoHV-4 is important 
in the epidemiology and represents a major hindrance to clini-
cal diagnosis.
Currently, it is still uncertain whether BoHV-4 plays a pri-
mary role in pathological processes in diseased animals or can 
potentiate clinical manifestations associated with the infection by 
another pathogen. Overall, the published data suggest that the 
pathogenic potential of the virus is low. However, BoHV-4 can 
exacerbate the clinical impact only when it is present with other 
infectious pathogens, which may induce reactivation of BoHV-4 
from latency (3, 29). BoHV-4 is currently considered as a cofac-
tor for the development of disease usually initiated by bacteria 
(3, 4, 34). Nevertheless, there is little information about the role 
of BoHV-4 in cattle diseases and about the clinical significance of 
coinfection with BoHV-4 and other animal viruses.
In 2009, the nasopharyngeal swabs from two dairy cows with 
pneumonia were submitted to the Diagnostic Veterinary Virology 
Laboratory (DVVL) of the Faculté de médecine vétérinaire (FMV) 
of the Université de Montréal (UdeM). The animals were located 
in a Quebec (Canada) dairy farm experiencing an outbreak of 
respiratory and reproductive diseases. The farm had 200 Holstein 
cows housed in free stalls. Several multiparous periparturient 
cows (n =  22) presented at least one of the following clinical 
conditions between April and May 2009: acute mastitis (n = 3), 
milk fever (n = 8), ketosis (n = 6), displaced abomasum (n = 1), 
downer cow (n = 1), retained placenta (n = 3), birth of stillborn 
calves (n = 3), abortion (n = 1), or pneumonia (n = 3), and three 
of those cows died. In June, a total of six cows died, and there were 
seven cows with pneumonia. Of those cows, four did not calved 
as expected during the summer period. Two tracheal aspirates 
were collected from two different cows experiencing pneumonia. 
Bacteria isolation diagnostic assays in one sample revealed the 
presence of Mycoplasma bovis and, in the second sample, revealed 
the presence of Arcanobacterium pyogenes, Pasteurella multocida, 
and Histophilus somni. This dairy herd was vaccinated on a 
continuous basis against BoHV-1, bovine viral diarrhea virus, 
parainfluenzavirus 3, and bovine respiratory syncytial virus in 
the first 30 days after calving, and against Escherichia coli mastitis 
during the dry period. Importantly, the BoHV-4 was isolated in 
cell culture from the two submitted swab samples. This intriguing 
finding prompted us to further characterize the virus genome using 
the next-generation sequencing (NGS) technology in attempt to 
determine whether the new BoHV-4 isolate was different from the 
known 66-p-347 and V.test BoHV-4 reference strains. Since very 
limited epidemiological data are available on the prevalence of 
BoHV-4 in Canada, a diagnostic serological assay was developed 
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and used to investigate the prevalence of the BoHV-4 in Canadian 
healthy and sick dairy animals and to establish if any correlation 
exists between BoHV-4 and cattle diseases.
MaTerials anD MeThODs
cells
Madin–Darby bovine kidney cells (MDBK, ATCC CCL-22, 
American Type Culture Collection, VA, USA) were used for 
BoHV-4 isolation and for serological assays, i.e., the immunofluo-
rescence assay (IFA). The MDBK cells were cultured in 
minimum essential medium with Earle’s salts (MEM) (Invitrogen 
Corporation, GibcoBRL, Burlington, ON, Canada), supplemented 
with 10% fetal bovine serum (FBS) (Wisent Inc., St-Bruno, QC, 
Canada), 300  U/mL of penicillin, 300  µg/mL of streptomycin, 
10 mM HEPES (Invitrogen Corporation, GibcoBRL, Burlington, 
ON, Canada), and maintained at 37°C and 5% CO2 in a humidi-
fied incubator.
Virus isolation
The nasopharyngeal swabs from two dairy cows with pneumonia 
were submitted to the DVVL of the Faculté de médecine vétéri-
naire (FMV) of the UdeM, in 2009. The animals were located in a 
Québec (Canada) dairy farm experiencing an outbreak of respira-
tory and reproductive diseases. Nasopharyngeal swab samples 
were immersed in MEM containing antibiotics at a concentration 
that was three times higher than described for maintenance of cell 
cultures, and were vigorously shaken and centrifuged at 750 g for 
10  min. The supernatants were filtrated (0.45  µm filter) before 
inoculation of 80% confluent monolayers of MDBK cells. Infected 
cells were incubated in MEM supplemented with 2% FBS at 37°C 
and 5% CO2 for 4  days. Virus isolation was conducted during 
three consecutive passages. The cultures were examined daily 
for the presence of cytopathic effect (CPE). Intracellular virions 
were released by three cycles of freezing at −80°C and thawing. 
Cellular debris was removed by centrifugation at 750 g for 10 min 
and the supernatant containing virions were stored at −80°C. 
Non-inoculated MDBK cells served as a negative control. To con-
firm the presence of the virus isolate (named FMV09-1180503/
BoHV-4-FMV), a transmission electron microscopy (TEM), a 
pan-herpesvirus nested PCR (nPCR) assay, and a specific IFA 
were conducted on virus-infected cell culture and cell lysates as 
described below.
Transmission electron Microscopy
When a CPE in infected cell culture was observed, the cell culture 
supernatant was first concentrated and then purified on a sucrose 
gradient by ultracentrifugation. Purified viruses were fixed with 
a 2% glutaraldehyde solution, stained and examined by TEM 
(Philips, model EM201 and Hitachi, model HT7700, Rexdale, 
ON, Canada). Briefly, 50  µL of purified-fixed viruses were 
ultracentrifuged (Airfuge, Beckman Coulter, Inc., Mississauga, 
ON, Canada) at 100,000 g/30 min to pellet virions directly onto a 
formvar coated copper grid (Canemco & Marivac, QC, Canada). 
The grids were then negatively stained using 2% phosphotungstic 
acid and 2% uranyl acetate and visualized by TEM for the detec-
tion of viral particles.
Pan-herpesvirus nPcr assay
Briefly, the pan-herpesvirus nPCR assay was performed as previ-
ously described (35). The nPCR amplified a variable region of 
the viral DNA polymerase (DPOL) gene. Thereafter, the PCR 
product, of more than 200 nucleotides in length, was sequenced 
(Sequencing Laboratory, FMV, Université de Montréal, QC, 
Canada) to confirm the presence of herpesvirus sequences.
immunofluorescence assay
For the identification of BoHV-4, monolayers of MDBK infected 
cells were fixed with cold 80% acetone solution for 10 min when 
CPE was evident (2  days after infection). After fixation, cells 
were rehydrated in phosphate-buffered saline solution (PBS, 
pH 7.2) and incubated for 30 min in a 1/30 dilution of rabbit 
anti-BoHV-4 serum (courtesy provided by Dr. Fernando Osorio, 
University of Nebraska, Lincoln, NE, USA). Subsequently, cell 
monolayers were washed three times with PBS and incubated for 
30 min in a 1/40 dilution of fluorescein isothiocyanate (FITC) 
conjugated goat anti-rabbit serum (Zymed Laboratories, San 
Francisco, CA, USA) and then washed three times with PBS. 
Cells were visualized using a DMI 4000B reverse fluorescence 
microscope and photographic images were taken with a DFC 
490 digital camera (Leica Microsystems Inc., Richmond Hill, 
ON, Canada).
To evaluate the seroprevalence of BoHV-4 and BoHV-1 in 
Quebec and Ontario cattle, antibodies titers were determined 
with an IFA (36). The virus strains used were FMV09-1180503 
(BoHV-4-FMV) and ATCCVR-864 (BoHV-1). Briefly, MDBK 
cells growing in 96-well microplates were infected with BoHV-1 
or -4. Infected cells were incubated in MEM supplemented with 
2% FBS at 37°C and 5% CO2. When CPE became apparent (2 days 
post-infection), infected cells were fixed with 4% paraformalde-
hyde in PBS solution. Cell monolayers were permeabilized by 
adding 0.1% Triton X-100 solution (in PBS) during 10 min at 
room temperature. After the permeabilization procedure, cells 
were incubated 30 min in PBS containing 0.2% Tween 20 and 
1% FBS. Cows’ sera were diluted through a series of twofold 
dilutions from 1/4 to 1/512 in the washing buffer (0.02% Tween 
20 in PBS) in separate microplates, added to the infected cells 
and incubated at room temperature for 90  min. Then, cell 
monolayers were washed three times with a solution contain-
ing 1% FBS in PBS-Tween 20 and incubated for 60 min in the 
washing buffer containing a 1/100 dilution of rabbit anti-bovine 
FITC conjugate antibody (5  mg/mL, MP Biomedicals, Solon, 
OH, USA). Finally, cell monolayers were washed three times as 
described above and observed by the DMI 4000B reverse fluo-
rescence microscope. Mock-infected cells and BoHV-1 and -4 
in-house selected positive bovine sera were used as controls. 
At the time when this study was conducted, the commercially 
available ELISA for BoHV-4 was not widely available. Since the 
manufacturing company is located in Belgium, we assumed that 
commercially available kit (BioX Diagnostics) was designed 
for European BoHV-4 strain. Therefore, it was crucial for our 
project to develop a serological assay using BoHV-4 Canadian 
field-related viral antigens such as the BoHV-4 isolated strain. 
Consequently, an IFA assay was developed using BoHV-4-FMV 
strain.
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high Throughput sequencing
Bovine gammaherpesvirus 4-FMV-infected MDBK cells were 
frozen and thawed three times. The lysates were precleared 
by centrifugation at 3,000  g for 20  min and supernatants were 
subjected to ultracentrifugation through 30% sucrose cushion 
in TNE buffer (50 mM Tris, pH 7.5; 140 mM NaCl and 5 mM 
EDTA), at 112,000 g for 5 h, using the SW28 Beckman Coulter 
rotor (Beckman Coulter Canada Inc., Mississauga, ON, Canada). 
The pelleted virus was resuspended in TNE buffer and ultracentri-
fuged through a cesium chloride (CsCl) equilibrium gradient (in 
TNE buffer) for 6 h at 154,000 g, using Sorvall TH-641 swinging 
bucket rotor (Kendro Laboratory Products, Newtown, CT, USA). 
A visible whitish band was collected by aspiration and the pres-
ence of the viral particles was confirmed by the pan-herpesvirus 
nPCR assay. CsCl purified virions were resuspended in 2 mL TE 
solution (10 mM Tris–hydrogen chloride [HCl], pH 7.5, 1 mM 
EDTA) containing 0.5% sodium dodecyl sulfate and 100  µg/
mL of proteinase K, which was mixed by brief agitation, then 
heated at 55°C for 30 min. Viral DNA was extracted by phenol-
chloroform-isoamylalcohol (25:24:1) and thereafter precipitated 
with ethanol and stored at −20°C. The purified viral DNA was 
submitted to the McGill University Génome Québec Innovation 
Center sequencing laboratories. The sample was sequenced on a 
Roche 454 GS FLX instrument using the Titanium chemistry. A 
total of 82,194 reads for a total of 23,875,823 bases was obtained 
which corresponds to a coverage of more than 200-folds of the 
LUR region of the viral genome. Genome assembly was per-
formed using Newbler software v2.6 (Roche, Life Technology). 
Sequence finishing was done using CLC Genomic Workbench 
v5 (CLC Bio, Redwood City, CA, USA). Gaps in the sequence 
assembly were resolved by performing PCR amplification cov-
ering these gaps and sequencing the amplicons by the Sanger 
method.
Dna sequence analysis
A pairwise comparison between the three complete BoHV-4 
genomes available in GenBank (accession numbers KC999113, 
AF318573, and JN133502 for BoHV-4-FMV, 66-p-347, and 
V.test, respectively) was performed. The number of substitutions 
and gaps between sequences was recorded in one-nucleotide 
sliding windows of 501 bp using the Python script.
The nucleotide sequences of the DPOL and the thymidine 
kinase (TK) genes were used to construct the molecular phy-
logenetic trees for different strains of herpesviruses. A set of 
herpesvirus sequences was available from GenBank sequences 
(non-redundant NT) with Blast+ (37). The sequences of the 
DPOL and the TK genes of BoHV-4-FMV were used as the query 
sequence. DNA sequences were then translated with transeq (38), 
and the multiple protein sequence alignment was performed 
with Kalign2 (39). The alignment was manually validated and 
corrected with SeaView (40). This allowed to align the nucleotide 
sequences with TranAlign software (38). Nucleotide sites for the 
phylogeny were selected with Gblocks (41). For the DPOL set, a 
total of 40 sequences (Table S1 in Supplementary Material) were 
used for herpesviruses (Alphaherpesvirinae, Betaherpesvirinae, 
and Gammaherpesvirinae) molecular phylogeny with a length 
of 1,555 nucleotides. For the TK set, a total of 27 sequences 
(Table S2 in Supplementary Material) were used for BoHV-4 
strains phylogeny with a length of 212 nucleotides.
Molecular phylogenetic trees were inferred from DNA 
sequences with the MrBayes program (42). The general time 
reversible model of nucleotide evolution with 16 Markov chain 
Monte Carlo analyses were applied over 4 runs for 400,000 
generations, sampling every 100 generations. Branch lengths are 
proportional to genetic distances (the scale bar units are substitu-
tions per aligned position).
epidemiological survey
A first set of serum samples analyzed in this study was convenient 
random samples collected in 2009 from dairy cattle herds that 
were submitted to two diagnostic laboratories for different pur-
poses (such as health surveillance and vaccination status). One 
sample was randomly collected from each herd. A total of 191 
sera were obtained from DVVL (Faculté de médecine vétérinaire, 
Université de Montréal, Québec, QC, Canada) and Animal 
Health Laboratory (University of Guelph, ON, Canada) for a 
general epidemiological assessment of BoHV-4 seroprevalence.
A second set of serum samples (n = 123) was collected in 2009 
and 2010 from specifically selected Quebec dairy cattle herds 
with no health issue (n = 48) or documented clinical problems 
(n = 75). The serum samples from healthy and clinically affected 
herds were randomly obtained from 4 herds (5–15 samples/
herd; one sample/animal) and 12 herds (1–15 samples/herd; 
one sample/animal), respectively. From the clinically affected 
herds, only diseased animals were sampled. Several animals from 
diseased herds were experiencing respiratory problems, cough, 
calving problems, abortion, embryonic death, retained placenta, 
metritis, mastitis, and unexplained fever that were affecting the 
herd performance. The BoHV-4 seroprevalence of healthy and 
diseased animals was determined by IFA and results obtained 
from both populations were compared.
statistical analyses
The serological data were not normally distributed. Thus, non-
parametric analyzes were conducted using the Mann–Whitney 
unpaired test. A contingency table with the Fisher’s exact test 
was used to determine whether the prevalence of BoHV-4 was 
significantly higher in diseased dairy cattle compared to healthy 
animals. The GraphPad Prism software version 5.03 (La Jolla, CA, 
USA) was used for the statistical analyzes. Values of P < 0.05 were 
considered to be significant.
resUlTs
BohV-4 isolation and identification
Bovine gammaherpesvirus 4 was isolated from cattle experiencing 
respiratory problems by infecting MDBK cells. The CPE observed 
was rounding cells in a shape of grape clusters, cellular death, 
and monolayer detachment (data not shown). The herpesvirus 
presence was confirmed by the visualization of the icosahedral 
viral capsid (measuring around 100–125  nm in diameter) and 
enveloped virus particles morphologically similar to viruses of the 
Herpesviridae family using negative-stain electron microscopy 
FigUre 1 | Transmission electron microscopy (TEM) image of bovine gammaherpesvirus 4 (BoHV-4)-FMV isolate and detection of its antigens by indirect 
immunofluorescence assay (IFA). (a) TEM image of BoHV-4-FMV virus isolate grown on MDBK cells, showing herpesvirus-like virions. Negative-stain TEM allows the 
visualization of enveloped (blue arrows) and non-enveloped (yellow arrow) herpesvirus particles. A more detailed icosahedral capsid structure of the virus with an 
overall size of 122 nm in diameter, with its capsomere subunits, is illustrated in the inset. (B) Visualization of BoHV-4-FMV MDBK-infected cells by a specific IFA. 
(c) Mock MDBK-infected cells.
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(Figure 1A), and by pan-herpesvirus nPCR assay (35) (data not 
shown). The sequencing of the pan-herpesvirus nPCR amplicon 
was done to confirm the identity of the virus. Immunofluorescent 
staining with a specific antibody against BoHV-4 revealed the 
presence of viral proteins in the nucleus and cytoplasm indicating 
the presence of the virus in infected cells (Figure 1B).
BohV-4 sequence analysis
Sequence assembly of reads from Roche 454 GS FLX and ampli-
con sequencing produced a sequence of 108,349 bp in length. This 
sequence corresponds to the LUR of BoHV-4-FMV (Figure 2A) 
and was submitted to GenBank (accession number KC999113). 
Overall, the genome of BoHV-4-FMV is quite similar to the two 
other LUR BoHV-4 genomes already published for 66-p-347 and 
V.test reference strains (7, 17).
Detailed analysis revealed that punctual high levels of variabil-
ity were present in various regions of the LURs (Figures 2B,C). 
Pairwise comparisons showed that regions with higher vari-
ability were mostly the same in the three virus sequences. Gaps 
were clearly more frequently located within the repeat regions 
than elsewhere in the genomes (Figure 2B). Important variations 
of the relative identity between the sequences were also seen 
within the repeat regions but also elsewhere (Figure 2C). Outside 
the repeat regions, sequence variability between the BoHV-4 
sequences was mostly observed within or in the vicinity of some 
Bo genes (Bo1, Bo3, Bo5, Bo8, Bo11, Bo12, Bo16, and Bo17). 
Based on the profiles shown in Figure 2 and particularly those of 
relative identity, it is tempting to propose that BoHV-4-FMV is 
the most divergent of the three strains. In order to confirm that, 
global distances between genome sequences were calculated using 
Kimura 2 parameters (K2p) substitution model. All gap positions 
were excluded before computing the values. The distances (in 
numbers of substitution per site) between genomes are as follows: 
0.0142 (BoHV-4-FMV versus 66-p-347), 0.0122 (BoHV-4-FMV 
versus V.test) and 0.0093 (66-p-347 versus V.test). The higher 
value of distance indicates a greater level of divergence between 
strains. Therefore, these results demonstrated that BoHV-4-FMV 
strain has the most diverging LUR sequence from the known 
BoHV-4 genomes.
As it was expected, the molecular phylogenetic analysis 
using the DPOL gene sequence of 40 herpesvirus species posi-
tioned the BoHV-4-FMV as well as the other BoHV-4 strains 
within the Gammaherpesvirinae subfamily (Figure  3) (7). More 
particularly, it appeared that BoHV-4 viruses grouped with her-
pesviruses infecting babirusa and Bornean bearded pigs. In the 
Gammaherpesvirinae subfamily, all the viruses within Rhadinovirus 
genera are clustered together (see * in Figure 3), which includes 
the BoHV-4 viruses as well as two viruses with unassigned genus 
FigUre 2 | Sequence comparison of the bovine gammaherpesvirus 4 (BoHV-4) long unique coding region (LUR) sequences. (a) Map of the BoHV-4 LUR genome. 
Every open reading frame is illustrated by a gray box. Upper boxes correspond to genes on the + strand, while the others are the genes on the − strand. Only some 
specific genes are indicated. The arrow indicates the position of the quasi-palindromic motif of the oriLyt region. (B) A pairwise comparison of the number of gaps 
between the three complete BoHV-4 genome sequences [FMV (BoHV-4-FMV), 66-p-347, and V.test] is shown. (c) A pairwise comparison of the relative identity 
between the three complete BoHV-4 genome sequences is shown. For both B and C, a 501 bp sliding window was used for the comparison. The gray areas shown 
in B and C represent the repeat regions (R1, R2a, R2b from left to right) found in the BoHV-4 genomes.
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(TterGHV-1 and PleoGHV-1). Based on the phylogenetic tree, 
it is possible that the genus of these two viruses could also be 
Rhadinovirus.
The molecular phylogeny of 27 BoHV-4 sequence strains 
obtained, using the TK gene is shown in Figure 4. This phylo-
genetic tree was constructed in a similar way as it was described 
by Verna et  al. (43), using the same dataset and adding the 
sequence of the TK gene of the three BoHV-4 strains for which 
a complete genome is available (BoHV-4-FMV, V.test, and 
66-p-347). The very same phylogeny was reproduced, while 
demonstrating that the TK gene of the three additional strains 
(BoHV-4-FMV, V.test, and 66-p-347) was clustered within the 
Genotype 1 group.
BohV-4 seroprevalence in canada
A low BoHV-4 seroprevalence was observed in cattle from 
Quebec and Ontario (6 and 9.9%, respectively). In contrast, the 
seroprevalence of BoHV-1 was much higher and reached 38% 
in Quebec and 37.4% in Ontario (Table 1). The relatively high 
BoHV-1 seroprevalence was probably due, in part, by the broad 
FigUre 3 | Molecular phylogeny of the DNA polymerase (DPOL) gene of various herpesvirus species. The phylogeny of DPOL gene sequences (1555 nucleotides 
in length) from 40 herpesviruses (Table S1 in Supplementary Material) was determined using MrBayes programs. Numbers on branches correspond to posterior 
probabilities. Branch length is proportional to the number of nucleotides substitutions. The tree is unrooted. The arrow points to the bovine gammaherpesvirus 4 
(BoHV-4)-FMV strain and the asterisk (*) highlights the Rhadinovirus genus cluster.
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use of BoHV-1 commercial vaccine in dairy cattle herds (8, 44). 
The seroprevalence of BoHV-4 and BoHV-1 for both provinces 
taken together were 7.9 and 37.7%, respectively. The cattle of 
both provinces seem to share similar serological patterns, since 
the differences between their respective BoHV-4 and BoHV-1 
seroprevalence were not significant (Table  1). The seropreva-
lence of BoHV-1 was used as a control in our study. Moreover, 
it was decided to test for BoHV-1 seroprevalence in order to 
evaluate the possible cross-reactivity of the BoHV-4 antibodies. 
Interestingly, several animals, which were negative for BoHV-1, 
were positive for BoHV-4, and vice versa, indicating that serologi-
cal cross-reaction between BoHV-1 and BoHV-4 antibodies was 
not a major concern to the present study.
Serological analyses of the second set of samples (from healthy 
and diseased animals from Quebec) revealed that BoHV-4 
seroprevalence was higher in animals presenting clinical signs of 
diseases (respiratory/reproductive problems) compared to healthy 
animals (50.6% compared to 29.2%, respectively) (P  <  0.05) 
(Table  2). Thus, clinically affected animals have a significantly 
higher risk to be seropositive for BoHV-4 compared to healthy 
animals (with a 2.494 odds ratio; Table 2). On the other hand, 
no significant difference in BoHV-1 seroprevalence was observed 
between healthy and diseased dairy cattle (60.5% compared to 
60%, respectively) (Table  2). Interestingly, a tendency toward 
higher antibody titers against BoHV-4 was observed in diseased 
animals compared to healthy animals (29.3 and 14.6% of animals 
with titers between 128 and 512, respectively). No difference was 
observed in the prevalence of animals having different levels of 
BoHV-1 antibody titers between diseased and healthy dairy cattle 
(Table 2).
TaBle 1 | Bovine gammaherpesvirus 4 (BoHV-4) and 1 (BoHV-1) seroprevalence 
in Quebec and Ontario provinces.
BohV-4 seroprevalence BohV-1 seroprevalence
Quebec 
samples 
(n = 100)
Ontario 
samples 
(n = 91)
Overall 
(n = 191)
Quebec 
samples 
(n = 100)
Ontario 
samples 
(n = 91)
Overall 
(n = 191)
6.0% 9.9% 7.9% 38.0% 37.4% 37.7%
No significant statistical difference (P > 0.05) was observed between Quebec and 
Ontario seroprevalence for both BoHV-4 and BoHV-1 using the non-parametric Mann–
Whitney test.
FigUre 4 | Molecular phylogeny of the Thymidine kinase (TK) gene from various bovine herpesvirus 4 strains. The phylogeny of TK gene sequences (212 
nucleotides in length) from 27 bovine gammaherpesvirus 4 (BoHV-4) strains (Table S2 in Supplementary Material) was determined using MrBayes programs. 
Numbers on branches correspond to posterior probabilities. Branch length is proportional to the number of nucleotides substitutions. The tree is unrooted.  
The arrow points to the BoHV-4-FMV strain. The reference strains Movar_33_63 and DN599 are in bold.
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never been isolated from cell cultures for the past 12 years in our 
diagnostic laboratory (DVVL). However, a diagnostic assay for 
bacteria isolation revealed the presence of M. bovis in one sample. 
In the second swab sample, the assay revealed the presence of A. 
pyogenes, P. multocida, and H. somni (data not shown). Due to the 
identification of M. bovis (and other bacteria) in the same sample, 
BoHV-4 was not considered to be the primary etiological agent 
of the respiratory disease. Unfortunately, no data on M. bovis 
seroprevalence are available for the Quebec’s herds included in 
the present study. In a recent study realized in Quebec, M. bovis 
has been detected by PCR and culture in nasal swabs of 20% of 
dairy calves, in a relatively small size sample (45). Furthermore, 
it was found that the prepartum nutritional program of the herd 
was deficient in vitamin E, energy, and protein (data not shown), 
which also could contributed to the health status of the dairy 
cattle. Nonetheless, since very limited data about the BoHV-4 
DiscUssiOn
The isolation of BoHV-4 from dairy cattle experiencing respira-
tory problems was an unexpected finding because this virus has 
TaBle 2 | Bovine gammaherpesvirus 4 (BoHV-4) and 1 (BoHV-1) seroprevalence in diseased dairy cattle.
BohV-4 seroprevalence BohV-1 seroprevalence
immunofluorescence  
assay results
antibodies titers healthy animals %/(n) Diseased animals %/(n) healthy animals %/(n) Diseased animals %/(n)
Negative <8 70.8/(34) 49.3/(37) 39.6/(19) 40.0/(30)
Positive 8–64 14.6/(7) 21.3/(16) 43.8/(21) 41.3/(31)
128–512 14.6/(7) 29.3/(22) 16.7/(8) 18.7/(14)
Total 100 (48) 100 (75) 100 (48) 100 (75)
ORa: 2.494 [1.155–5.386]* OR: 0.983 [0.4687–2.061]
aOR, odds ratio. Numbers in brackets represent the 95% confidence interval.
*P < 0.05 (Fisher’s exact test).
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prevalence, the type of circulating viral strains, and their patho-
genic potential in Canada are available, we aimed to investigate 
these research questions.
The complete viral LUR sequence of the Canadian BoHV-4 
isolate (FMV09-1180503, BoHV-4-FMV) was sequenced with 
the help of deep sequencing technology. Next, the analysis of the 
LUR sequence of BoHV-4-FMV strain was compared with the 
two other available BoHV-4 LUR viral genomes. It appeared that 
the BoHV-4-FMV strain was the most divergent viral genome in 
this group. Notably, virus genomic differences can potentially lead 
to different pathogenic potential. This was recently demonstrated 
in  vitro when replication kinetics and virus titers of different 
BoHV-4 strains were compared (46). Most of the divergences 
between BoHV-4 genomes were in the Bo genes and in the repeat 
regions (Figure 2). In fact, these regions are in general those with 
the highest divergence between the three BoHV-4 strains.
As expected, the DPOL gene phylogenetic analysis confirmed 
that BoHV-4-FMV belongs to Gammaherpesvirinae (Figure 3) 
(7). However, it was surprising that the phylogeny of the TK gene 
placed the BoHV-4-FMV Canadian isolate within the European 
group (Genotype 1) (43). The V.test and 66-p-347 strains also 
belong to this genotype, which seems to be logical because both 
have been isolated in European countries. There are three possible 
explanations for the unexpected grouping of the BoHV-4-FMV 
strain within genotype 1. First possibility: this strain is originally 
from Europe and was introduced into North America by the 
importation of animal carriers or contaminated bovine products. 
Second, as it was suggested by Verna et al. (43), the phylogenetic 
analysis based only on the TK gene is not powerful enough, and 
additional markers or strains are needed in order to create a 
more accurate picture of the BoHV-4 genomic diversity. Third, 
the unexpected grouping is a result of previous recombination 
events. In fact, evolution of herpesviruses for a long time has 
been attributed, at least in part, to the process of recombination. 
The NGS technologies have greatly increased the accuracy of 
the detection of genetic recombination events, single nucleotide 
polymorphisms, and minor mutations. Significantly, high rates 
of in  vivo intra-species homologous recombinations have been 
demonstrated, for example, for herpes simplex virus-1 and 
BoHV-1, which corroborate the important role of recombination 
in herpesvirus diversification and evolution (47, 48).
Our second goal was to elucidate any potential association 
between BoHV-4 infection and diseases in cattle. Previous studies 
showed that the IFA is highly specific for detection of BoHV-4 
antibodies and proved that there is no cross-reactivity between 
BoHV-1 and BoHV-4 (49). Therefore, we used this approach 
in our study. The present epidemiological survey, conducted in 
Canadian dairy cattle, showed that BoHV-4 seroprevalence was 
very low compared to other reports, which may explain why 
BoHV-4 is rarely detected by Canadian veterinary diagnostic 
laboratories, including our diagnostic laboratory (DVVL). For 
instance: compared with the value of 8.9% reported in Japan (50); 
23.3% (dairy cattle) to 33.3% (beef cattle) in Northern Ireland 
(51); 84, 79, and 13.8% in 3 Dutch dairy herds (52); and 36, 83, 
and 84.4% in animals with a history of metritis from Georgia, 
USA (53), Spain (54), and Belgrado, Serbia (55), respectively. 
Other studies that investigated the role of this virus in clinical 
and/or subclinical mastitis in Canadian dairy cows detected anti-
bodies against BoHV-4 in a high amount of milk samples (98%) 
(29). It is very hard to reconcile these data with our BoHV-4 
seroprevalence results that are much lower. In fact, some details 
of the experimental design (e.g., the selection criteria of milk 
samples) are missing in that report, which do not allow us to 
understand this discrepancy. Notably, it is evident that the subset 
of milk samples tested by Ali and collaborators was not a random 
representation of dairy cows (29). In fact, the prevalence of milk 
samples positive for Staphylococcus aureus was 28.5% according 
to Ali et al. (29), while it was reported to be around 3% for the 
repository of the Canadian milk samples collected randomly (56). 
The samples studied by Ali et al. have been taken from this reposi-
tory. Consequently, we can speculate that discrepancy between 
these two reports and the discrepancy between Ali et al. and ours 
data (regarding the BoHV-4 seroprevalence) could be explained 
by a bias sampling by Ali et al. (29).
More interestingly, the antibody titers against BoHV-4 in 
the present study were higher in diseased animals compared to 
healthy animals. Our results suggest that BoHV-4 can potentially 
have a role in bovine diseases, i.e., can affect the respiratory and 
reproductive systems of animals. The possibility that BoHV-4 may 
play a causal role in the development of disease is still uncertain, 
because the virus has been found in both clinical cases (4, 18, 21, 
22, 25, 28) and healthy asymptomatic animals. Nevertheless, an 
increasing number of studies consider BoHV-4 as a risk factor for 
reproductive tract infections (21, 22, 31). Several other studies have 
proposed that BoHV-4 was a secondary agent, which was often 
associated with concomitant or secondary bacterial infections 
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(3, 4, 34). Therefore, in the context of coinfection and synergy 
with other pathogens, the higher BoHV-4 seroprevalence in cattle 
with respiratory or reproductive diseases can be expected. Hence, 
our study supports the suggestion that BoHV-4 is a frequent risk 
or a secondary factor in cattle infections/diseases.
The indirect role of BoHV-4 as a potential causative agent of 
disease in cattle was reinforced by our finding of the concomitant 
infection by M. bovis, which is a well-known pathogen that causes 
respiratory diseases in cattle (57). The emergence of BoHV-4 can 
be explained by the presence of a primary agent that triggers 
the reactivation of latent BoHV-4 infection (3, 29). In fact, it 
has been demonstrated that BoHV-4 infects macrophages and 
that immune cells can become persistently infected (31). On the 
other hand, it has been suggested that BoHV-4 can contribute 
to disease by lytic replication in host cells such as macrophages, 
thereby increasing inflammation and contributing to the vascular 
tissue damage (19, 58). This hypothesis is supported by a positive 
association between the presence of antibodies against BoHV-4 
in cattle and the incidence of bovine mastitis caused by S. aureus, 
suggesting that previous infection with BoHV-4 promotes the 
development of mastitis caused by bacteria (52). A possible 
immunosuppressive effect of BoHV-4 on the host immune sys-
tem has also been studied because persistence and isolation from 
cells of the immune system (spleen, blood leukocytes) indicate a 
potential relation to the immune response (9).
Additionally, BoHV-1 seroprevalence was found to be 
relatively high in our study (37.7% in the overall population and 
about 60% in diseased animals). However, these data and asso-
ciation with cattle diseases should be investigated further and 
considered with caution because BoHV-1 vaccines are widely 
used in Canada.
To our knowledge, this is the first report of the nearly complete 
viral genome of a Canadian BoHV-4 isolate. When compared 
against the two reference strains, this Canadian BoHV-4 strain 
showed a certain level of divergence. In addition, a low BoHV-4 
seroprevalence was found in two Canadian provinces. The highest 
seroprevalence of BoHV-4 has been found in cattle with respiratory 
and reproductive diseases. However, based on previous reports, it 
is uncertain whether the BoHV-4 is the primary causative agent 
of the disease. Thus, it is plausible to suggest that BoHV-4 can 
act as a synergistic cofactor for some of these diseases, acting as 
a secondary pathogen that can be triggered in a suitable envi-
ronment. For example, the immunosuppressive circumstances 
generated by other pathogens may favor the BoHV-4 reactivation, 
which consequently will contribute to aggravating any infectious 
diseases.
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